Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Boyd Steven
Relationship:   10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   18    
Direct Shares   47,075,098    

Indirect Shares

  40,287,245      
Direct Value   $123,263,793    

Indirect Value

  $39,962,337      
Total Shares   87,362,343      
Total Value   $163,226,130      


Avalo Therapeutics, Inc
 $14,783 Dynatronics Corp
 $233,800 Kiora Pharmaceuticals
 $625,814 Fresh Tracks Therapeutics Ord Shs
 $1,466,920 Alimera Sciences Inc
 $2,115,480 Cassava Sciences Inc
 $31,491,054 Bio-Path Holdings, Inc.
 $46,806 AYTU BIOSCIENCE, INC
 $3,933,168 Achieve Life Sciences Inc
 $4,404,511 AMAG Pharmaceuticals Inc
 $56,650,000 Onconova Therapeutics, Inc.
 $596,192 Vaxart Inc
 $110,277 Tenax Therapeutics Inc
 $524,997 Cyclo Therapeutics, Inc
 $20,218,584 ReShape Lifesciences Inc
 $831,407 Avalo Therapeutics, Inc
 $14,783 Dynatronics Corp
 $233,800 Kiora Pharmaceuticals
 $625,814 Fresh Tracks Therapeutics Ord Shs
 $1,466,920 Alimera Sciences Inc
 $2,115,480 Cassava Sciences Inc
 $31,491,054 Bio-Path Holdings, Inc.
 $46,806 AYTU BIOSCIENCE, INC
 $3,933,168 Achieve Life Sciences Inc
 $4,404,511 AMAG Pharmaceuticals Inc
 $56,650,000 Onconova Therapeutics, Inc.
 $596,192 Vaxart Inc
 $110,277 Tenax Therapeutics Inc
 $524,997 Cyclo Therapeutics, Inc
 $20,218,584 ReShape Lifesciences Inc
 $831,407
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    99   
    96    

     Stock price went up :

    54   
    46    
     Stock price went down :
    45   
    50    
   
     Gain/Loss Ratio :
   1.2   
   1.2   
     Percentage Gain/Loss :
   -16.7%
 8,928.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Avalo Therapeutics, Inc AVTX 10% Owner 2023-06-27 34,370 2023-06-27 731,458    Premium*  
            Dynatronics Corp DYNT 10% Owner 2017-03-21 500,000 2017-03-21 1,000,000    Premium*  
            Kiora Pharmaceuticals KPRX 10% Owner 2021-01-06 3,346,601 2021-08-02 785,000    Premium*  
            Fresh Tracks Therapeutics Ord Shs FRTX 10% Owner 2019-01-10 2,170,000 2019-01-10 2,170,000    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2018-02-06 6,936,000 2018-02-06 6,936,000    Premium*  
            Cassava Sciences Inc SAVA 10% Owner 2018-10-03 1,651,340 2018-10-03 0    Premium*  
            Del Friscos Restaurant Group, Llc DFRG 10% Owner 2019-09-25 0 2019-09-25 0    Premium*  
            Valeritas Holdings Inc VLRX 10% Owner 2019-12-20 0 2019-12-20 0    Premium*  
            Bio-Path Holdings, Inc. BPTH 10% Owner 2019-01-18 129,298 2019-01-18 129,298    Premium*  
            AYTU BIOSCIENCE, INC AYTU Director 2021-03-29 1,342,378 2021-03-29 1,342,378    Premium*  
            Achieve Life Sciences Inc ACHV 10% Owner 2019-06-11 843,776 2019-06-11 843,776    Premium*  
            AMAG Pharmaceuticals Inc AMAG 10% Owner 2020-03-16 4,120,000 2020-03-16 348,000    Premium*  
            Onconova Therapeutics, Inc. ONTX 10% Owner 2019-09-23 816,702 2019-09-23 816,702    Premium*  
            Vaxart Inc VXRT Director 2020-06-29 145,523 2020-06-29 145,523    Premium*  
            Tetraphase Pharmaceuticals Inc TTPH Director, 10% Owner 2020-07-28 0 2020-07-28 0    Premium*  
            Tenax Therapeutics Inc TENX Director, 10% Owner 2020-09-08 2,019,995 2020-09-08 2,019,995    Premium*  
            Cyclo Therapeutics, Inc CYTH 10% Owner 2020-09-30 15,795,769 2020-09-30 15,795,769    Premium*  
            ReShape Lifesciences Inc RSLS 10% Owner 2021-06-28 7,223,346 2021-06-28 7,223,346    Premium*  
* Premium Members only  

Records found :    790         Free Registration Required For Full Results.    Limit: 25

Download
  Page 17 of 32
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
KPRX Kiora Pharmaceuticals Director   –       •       •   2019-03-27 4 B $0.35 $42,226 D/D 120,647 17,383,500 3.92 -
VXRT Vaxart Inc 10% Owner   –       –       •   2019-10-01 4 B $0.35 $64,178 D/D 183,367 24,183,367 2.45 -
VXRT Vaxart Inc 10% Owner   –       –       •   2019-10-04 4 B $0.35 $95,900 D/D 274,000 24,710,000 2.45 -
VLRX Valeritas Holdings Inc 10% Owner   –       –       •   2018-11-27 4 B $0.36 $53,850 D/D 150,000 19,500,000 2.45 -
VLRX Valeritas Holdings Inc 10% Owner   –       –       •   2018-12-06 4 B $0.36 $17,845 D/D 50,000 19,550,000 2.37 -
VXRT Vaxart Inc 10% Owner   –       –       •   2019-10-02 4 B $0.36 $8,609 D/D 23,913 24,207,280 2.37 -
VXRT Vaxart Inc 10% Owner   –       –       •   2019-10-07 4 B $0.37 $107,300 D/D 290,000 25,000,000 2.45 -
KPRX Kiora Pharmaceuticals 10% Owner   –       –       •   2018-04-16 4 B $0.38 $435,731 D/D 1,159,167 11,816,890 2.45 -
VLRX Valeritas Holdings Inc 10% Owner   –       –       •   2018-11-20 4 B $0.38 $77,550 D/D 200,000 19,000,000 2.45 -
VLRX Valeritas Holdings Inc 10% Owner   –       –       •   2018-11-21 4 B $0.38 $49,729 D/D 130,000 19,130,000 2.37 -
VLRX Valeritas Holdings Inc 10% Owner   –       –       •   2018-11-26 4 B $0.38 $83,475 D/D 220,000 19,350,000 2.45 -
KPRX Kiora Pharmaceuticals Director   –       •       •   2018-12-10 4 B $0.39 $27,474 D/D 69,400 17,231,900 3.92 -
KPRX Kiora Pharmaceuticals Director   –       •       •   2018-11-14 4 B $0.41 $22,668 D/D 55,129 16,857,629 3.92 -
VLRX Valeritas Holdings Inc 10% Owner   –       –       •   2018-11-16 4 B $0.41 $20,590 D/D 50,000 18,800,000 2.37 -
KPRX Kiora Pharmaceuticals Director   –       •       •   2018-12-11 4 B $0.41 $12,842 D/D 30,953 17,262,853 3.92 -
KPRX Kiora Pharmaceuticals Director   –       •       •   2018-11-15 4 B $0.43 $55,003 D/D 126,735 16,984,364 3.92 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-04-28 4 B $0.44 $198,000 D/D 450,000 2,795,714 2.45 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-04-28 4 B $0.44 $396,000 I/I 900,000 2,795,714 1.5 -
KPRX Kiora Pharmaceuticals 10% Owner   –       –       •   2018-04-17 4 B $0.44 $837,670 D/D 1,895,610 13,712,500 2.45 -
KPRX Kiora Pharmaceuticals 10% Owner   –       –       •   2018-05-04 4 B $0.45 $38,866 D/D 85,748 16,498,248 2.37 -
KPRX Kiora Pharmaceuticals 10% Owner   –       –       •   2018-04-18 4 B $0.47 $370,158 D/D 781,254 14,493,754 2.45 -
KPRX Kiora Pharmaceuticals Director   –       •       •   2018-11-16 4 B $0.47 $83,724 D/D 178,136 17,162,500 3.92 -
KPRX Kiora Pharmaceuticals 10% Owner   –       –       •   2018-04-19 4 B $0.48 $599,299 D/D 1,256,920 15,750,674 2.45 -
KPRX Kiora Pharmaceuticals 10% Owner   –       –       •   2018-05-07 4 B $0.48 $6,888 D/D 14,252 16,512,500 2.37 -
KPRX Kiora Pharmaceuticals 10% Owner   –       –       •   2018-05-08 4 B $0.48 $17,718 D/D 37,230 16,549,730 2.37 -

  790  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17  18   19   20   21   22   23   24   25   26   27   28   29   30   31   32      
  Page 17 of 32  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed